5 Home Health startups to watch at INVEST Digital Health virtual Sept 21-25

Startups in the Home Health track for the Pitch Perfect contest span respiratory care and virtual nursing to health literacy, remote care and more.

Healthcare entrepreneurs are an essential part of the innovation landscape and they play center stage at several of MedCity’s events. At the upcoming MedCity INVEST Digital Health virtual conference September 21-25, held in partnership with Medical Alley, digital health startups will present to judges across four tracks as part of the Pitch Perfect competition.

At MedCity INVEST Digital Health virtualyou’ll hear from leading physician executives, payers, active investors and the most promising digital health startups aiming to solve some of healthcare’s greatest challenges. Click here to see agenda.

Here are the startups taking part in the Home Health track at INVEST Digital Health:

AireHealth is a virtual respiratory care company offering an in-home solution for at-risk, vulnerable, respiratory populations that can significantly improve outcomes, lower costs and reduce hospitalizations.

CEO: Stacie Ruth

Headquarters: Winter Park, FL

Elanza Wellness is a virtual nursing assistant service for fertility clinics that automates and augments aspects of care, aimed at radically improving patient experience whilst increasing throughput and saving time for clinics.

Co-founders: Catherine Hendy and Brittany Hawkins

Headquarters: San Francisco

Face2Face Health integrates health literacy e-learning courses; telemedicine access to multidisciplinary healthcare professionals, educators & advocates; expert-led webinars; & web-forum communities for sharing knowledge & support across 5 pillars of care: General Health, Emotional Health, Development, Mind/Body/Nutrition, and Education/Advocacy.

CEO: Ami Shah

Headquarters: New York, NY

Omcare is digital health company pioneering a product platform that enables remote care in the home, extends the reach of caregivers, and redefines medication adherence.

CEO: Lisa Lavin

Headquarters: Burnsville, MN


Vigilant Diagnostics LLC, founded in 2014, has developed patented Thermal Contrast Technology (TCA) that increases the sensitivity of Lateral Flow Assays (LFAs) by 10 to 250 times, allowing for faster and more accurate diagnostic results, with fewer false negatives and false positives. The company’s patent was developed at the University of Minnesota.

Co-CEOs: Richard C. Carlson and Frank F. Jiang, MD, PhD

Headquarters: Minneapolis, MN

Sponsors for the conference include: UnityPoint Health VenturesFredrikson & Byron, and Deloitte.

All the sessions will be recorded and be available to attendees upon request.

Tickets are available for $149 but an early-bird rate is available for $49 if you register now with the code MCN100. Companies can opt to purchase 10 tickets for a corporate group rate of $399.

Picture: uzenzen, Getty Images